High expression of programmed death-ligand 1 (PD-L1) has been reported as a negative prognostic factor in ovarian cancer, and the PD-1/PD-L1 axis can be a target for restoring antitumor immunity [12]. Here, PDCD1 is linked to ovarian carcinoma.